Sign in

Jan Hartmann, M.D.

@janhartmannmd.bsky.social
172 followers 54 following 87 posts

Bringing Med to MedTech - Physician, Scientist, Photographer, Traveler, Berliner, Immigrant 🇩🇪🇺🇸 - Views=My own, Like/RT≠Endorsement; Haemonetics employee

PostsRepliesMedia
Reposted by Jan Hartmann, M.D.
The Lancet @thelancet.com · 22/09/2026
Peripheral arterial disease (PAD) affects more than 300 million people worldwide—yet it remains under-recognised, underdiagnosed, and undertreated. A new Series aims to address this major health burden: spkl.io/633217rwP1
Figure showing typical regions of vessel involvement in people with PAD and illustration of the life course of affected people from asymptomatic PAD through intermittent claudication to CLTI, with reported progression rates and major amputation risk as well as death rates at the symptomatic disease stage. CLTI=chronic limb-threatening ischaemia. PAD=peripheral arterial disease. Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.
0105
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 19/09/2026
ABO Nonidentical Transfusions and Mortality in Massive Transfusion Protocol jamanetwork.com/journals/jam...
jamanetwork.com
ABO Nonidentical Transfusions and Mortality in Massive Transfusion Protocol
This cross-sectional study analyzes associations of ABO nonidentical transfusions with mortality among patients undergoing massive transfusion protocol.
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 14/09/2026
jamanetwork.com/journals/jam...
jamanetwork.com
Balanced Component and Whole-Blood Transfusion Practices
This cohort study evaluates trends, between-hospital variation, and patient and institutional factors associated with balanced component and whole-blood transfusion in US trauma centers.
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 10/09/2026
www.nejm.org/doi/full/10....
nejm.org
Reengineering Coagulation with a Bispecific Antibody | NEJM
Kunihiro Hattori, Tomoyuki Igawa, and Takehisa Kitazawa, who developed a prophylactic therapy for hemophilia A, have received the 2026 Lasker–DeBakey Clinical Medical Research Award.
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 19/05/2026
www.nejm.org/doi/full/10....
nejm.org
Prehospital Resuscitation with Type O Whole Blood for Trauma and Hemorrhage | NEJM
Blood transfusion before arrival at a hospital reduces mortality from traumatic hemorrhage and shock. Whether transfusion with whole blood is more beneficial than transfusion with blood components ...
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 10/01/2026
Contemporary Operator Procedural Volumes and Outcomes for TAVR and MTEER in the US url: jamanetwork.com/journals/jam...
jamanetwork.com
Contemporary Operator Procedural Volumes and Outcomes for TAVR and MTEER in the US
This cohort study determines whether an operator-level association of volume and outcomes exists for transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER) ...
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 05/01/2026
Age-Adjusted D-Dimer Cutoff in Suspected Deep Vein Thrombosis url: jamanetwork.com/journals/jam...
jamanetwork.com
Age-Adjusted D-Dimer Cutoff in Suspected Deep Vein Thrombosis
This prospective management outcome study conducted at multiple centers in Belgium, Canada, France, and Switzerland assesses whether using an age-adjusted D-dimer cutoff allows clinicians to safely ru...
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 18/12/2025
Our article on the trial of the HN cartridge for the TEG® 6s system featured in current issue of @anesthesiology.bsky.social. A big thank you to our team of co‑authors, local PIs and their teams, and all the participating patients who made this possible. www.linkedin.com/posts/anesth...
linkedin.com
#anesthesiology #anesthesiologist #anesthesia #medicalresearch | Anesthesiology Journals
A heparinase-containing cartridge for the TEG® 6s system to neutralize this effect was recently cleared by the U.S. Food and Drug Administration, but validation in clinical settings had been limited. ...
031
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 12/12/2025
www.linkedin.com/posts/haemon...
linkedin.com
#teg6s #cardiacsurgery #patientbloodmanagement #hemostasis #medicalresearch | Haemonetics
A multicenter study highlighted in Anesthesiology Journals clinically validated our TEG® 6s Global Hemostasis – HN cartridge by demonstrating high correlation with established assays in heparinized pa...
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 09/11/2025
Liberal or Restrictive Postoperative Transfusion in Cardiac Risk jamanetwork.com/journals/jam...
jamanetwork.com
Liberal or Restrictive Postoperative Transfusion in Cardiac Risk
This randomized clinical trial tests whether a liberal compared with a restrictive transfusion strategy lowers the risk of a cardiac event 90 days after major vascular or general surgery among patient...
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 24/10/2025
Preparing the Civilian Health Care System for Wartime url: jamanetwork.com/journals/jam...
jamanetwork.com
Preparing the Civilian Health Care System for Wartime
This Viewpoint discusses the need for the US health care system to prepare for war casualties through military and civilian health care collaboration.
010
Reposted by Jan Hartmann, M.D.
NEJM.org @nejm.org · 01/10/2025
Monoclonal gammopathy of undetermined significance is a common, asymptomatic plasma-cell disorder in older adults that can progress to cancer or systemic illness. Diagnosis warrants follow-up, but treatment is not required unless progression is confirmed. Learn more: nej.md/473uOsj
An illustrated diagram of the pathogenesis and progression of monoclonal gammopathy of undetermined significance (MGUS).
095
Reposted by Jan Hartmann, M.D.
Albert and Mary Lasker Foundation @laskerfdn.bsky.social · 15/09/2025
“For physician–scientists conducting early clinical trials, the results could best be described as miraculous.” 🧪 2025 #LaskerAward winners M. Welsh, J. González, & P. Negulescu developed life-saving #cysticfibrosis treatments. @nejm.org #Lasker2025
nejm.org
Transformative Research in Cystic Fibrosis | NEJM
Michael Welsh, Jesús González, and Paul Negulescu have won the 2025 Lasker–DeBakey Clinical Medical Research Award for their roles in developing treatments for cystic fibrosis.
0158
Reposted by Jan Hartmann, M.D.
Albert and Mary Lasker Foundation @laskerfdn.bsky.social · 15/09/2025
“The insights of Görlich, McKnight, and their colleagues are being harnessed in medical research.” 🧪 Read how low-complexity domains of proteins impact human health in @nejm.org #LaskerAward #Lasker2025 @mpi-nat.bsky.social #phaseseparation #biophysics www.nejm.org/doi/full/10....
nejm.org
Surprisingly Complex Assemblies from Low-Complexity Domains | NEJM
Drs. Görlich and McKnight have won the 2025 Albert Lasker Award for Basic Medical Research for showing that low-complexity domains of proteins lack structure on their own and yet can form assembled .....
053
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 13/09/2025
www.nature.com/articles/s41...
nature.com
Soluble tissue factor generated by necroptosis-triggered shedding is responsible for thrombosis - Cell Research
Cell Research - Soluble tissue factor generated by necroptosis-triggered shedding is responsible for thrombosis
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 08/09/2025
"Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants" ascpt.onlinelibrary.wiley.com/doi/abs/10.1...
ascpt.onlinelibrary.wiley.com
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel‐Treated Participants
Black individuals undergoing percutaneous coronary intervention (PCI) experience higher rates of major adverse cardiovascular events (MACE) than non-Black individuals. This study assessed the racial ...
021
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 08/09/2025
"Long-Term Outcomes of the DanGer Shock Trial" www.nejm.org/doi/full/10....
nejm.org
Long-Term Outcomes of the DanGer Shock Trial | NEJM
In patients with STEMI with cardiogenic shock, early mechanical support with a microaxial pump reduced the risk of death at 180 days, with the survival benefit persisting up to 10 years despite dev...
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 08/09/2025
"Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation" jamanetwork.com/journals/jam...
jamanetwork.com
Discontinuation of Anticoagulant Therapy After Catheter Ablation for Atrial Fibrillation
This randomized clinical trial compares discontinuing vs continuing oral anticoagulant therapy in patients without documented atrial arrhythmia recurrence after catheter ablation for atrial fibrillati...
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 08/09/2025
"Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis" www.thelancet.com/journals/lan...
thelancet.com
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis
These findings add to the evidence that clopidogrel monotherapy is superior to aspirin monotherapy for MACCE prevention with no increase in the risk of bleeding, and support the preferential use of cl...
001
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 08/09/2025
Good thing I don't drink coffee... news.cuanschutz.edu/news-stories...
news.cuanschutz.edu
Study Reveals Caffeine May Undermine Blood Transfusion Effectiveness
Study Reveals Caffeine May Undermine Blood Transfusion Effectiveness
000
Reposted by Jan Hartmann, M.D.
NEJM.org @nejm.org · 03/09/2025
In patients with heparin-induced thrombocytopenia, pathogenic antibodies were found to be monoclonal, which challenges previous views of HIT as a polyclonal disorder and suggests new avenues for diagnosis and treatment. Full study results: nej.md/4pkaYAq #MedSky #CardioSky
Figures showing the detection and function of anti–PF4–heparin antibodies from patients with heparin-induced thrombocytopenia.
0145
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 30/08/2025
Rainbow over Sandy Bay – Rockport, MA 🌈
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 06/08/2025
Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis url: academic.oup.com/eurheartj/ar...
academic.oup.com
Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
AbstractBackground and Aims. Dual antiplatelet therapy (DAPT) de-escalation strategies improve outcomes after percutaneous coronary intervention (PCI) comp
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 01/08/2025
A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery | New England Journal of Medicine www.nejm.org/doi/full/10....
nejm.org
A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery | NEJM
Patients undergoing cardiac surgery often receive red-cell transfusions, along with the associated risks and costs. Early intraoperative normovolemic hemodilution (i.e., acute normovolemic hemodilu...
000
Reposted by Jan Hartmann, M.D.
NEJM.org @nejm.org · 13/07/2025
In the BATURA phase 3b trial, as-needed albuterol–budesonide resulted in a lower risk of severe asthma exacerbation than as-needed albuterol among participants with disease that was uncontrolled despite treatment for mild asthma. Full trial results and Research Summary: nej.md/43uVpwK
The New England Journal of Medicine              
As-Needed Albuterol–Budesonide in Mild Asthma 
A Research Summary based on LaForce C et al. | 10.1056/NEJMoa2504544 | Published on May 19, 2025  

Visual representations of the patients in the trial and the treatments they were assigned.                  

Read the full Research Summary at NEJM.org.
2123
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 11/07/2025
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation | New England Journal of Medicine www.nejm.org/doi/abs/10.1...
nejm.org
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation | NEJM
Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence t...
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 22/06/2025
Last night at #ISTH2025, we honored a gentle giant—Dr. Hau Kwaan, Professor Emeritus at ⁦‪⁦‬⁩Northwestern. A true #Fibrinolysis pioneer with 400+ articles since the 1950s—still contributing posters in his 90s. Thanks, Mark Walsh, for a moving laudatio. @isth.org www.linkedin.com/posts/janhar...
linkedin.com
Later last night at #ISTH2025, we had the privilege of honoring a gentle giant of the field—Dr. | Jan Hartmann, M.D.
Later last night at #ISTH2025, we had the privilege of honoring a gentle giant of the field—Dr. Hau Kwaan, MD, PhD, FRCP, FACP, Professor Emeritus at Northwestern University - The Feinberg School of M...
081
Reposted by Jan Hartmann, M.D.
Michael Mina MD,PhD @michaelmina.bsky.social · 11/06/2025
It’s Code Red for Vaccines The number of changes to vaccine policy is dizzying & RFK Jr is just getting started! Dissolving the group of experts that drive policy is declaring war on “what was” I write in @nytimes.com about what is and is not working www.nytimes.com/2025/06/11/o...
nytimes.com
Opinion | It’s Code Red for Vaccines in America (Gift Article)
How to make sense of all the vaccine policy changes.
45125
Reposted by Jan Hartmann, M.D.
Nature @nature.com · 10/06/2025
This tiny device can shrink dangerous blood clots. It’s called the ‘milli-spinner’ and its invention was partly an accident…
27590132006
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 09/06/2025
bbc.com/news/article...
bbc.com
NHS calls for 200,000 new blood donors as supplies run low
The health service issued an "amber alert" last year and stocks remain low ever since.
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 09/06/2025
2024 EACTS/EACTAIC Guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP url:https://academic.oup.com/ejcts/article/67/5/ezae352/7815985
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 08/06/2025
Public radio in Boston… 📻 ⁦‪ ⁦‬⁩ #BumpaSticka @npr.org @wbur.org
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 05/06/2025
🇺🇸 🇩🇪 www.espn.com/nhl/story/_/...
espn.com
Bruins turn to ex-forward Sturm as head coach
The Boston Bruins hired Marco Sturm as coach on Thursday to help the Original Six franchise get back to the playoffs after missing them for the first time since 2016.
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 29/05/2025
jamanetwork.com/journals/jam...
jamanetwork.com
Platelet Transfusion International Clinical Practice Guidelines
This Special Communication discusses the updated Association for the Advancement of Blood and Biotherapies and the International Collaboration for Transfusion Medicine Guidelines international clinica...
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 08/05/2025
If you read one thing today, make it this: an epochal speech by the German President on the occasion of the 80th anniversary of Germany's capitulation at the end of WW2. www.bundespraesident.de/SharedDocs/R...
bundespraesident.de
“We are all children of 8 May”
On the 80th anniversary of the end of the Second World War, Federal President Steinmeier has called for remembrance not to become routine. “Our history is a precious treasure trove of experience. Let us trust in our experience,” he said at a commemoration ceremony in the Bundestag.
000
Reposted by Jan Hartmann, M.D.
NEJM.org @nejm.org · 02/05/2025
For a woman with device-detected atrial fibrillation, would you initiate anticoagulant therapy or recommend continuation of antiplatelet therapy? Read the case vignette and essays on both treatment options and cast your vote: nej.md/4lQzxTA #MedSky #CardioSky #Afib
CLINICAL DECISIONS 
Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation 

An illustration of a smartwatch monitoring ECG and two bottles, one containing an anticoagulant, and the other containing aspirin
396
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 01/05/2025
www.nejm.org/doi/full/10....
nejm.org
Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation | NEJM
This feature about a woman with device-detected atrial fibrillation offers a case vignette accompanied by two essays, one supporting the initiation of anticoagulant therapy and the other ...
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 30/04/2025
academic.oup.com/bjs/article-...
academic.oup.com
Tranexamic acid for trauma: optimal timing of administration based on the CRASH-2 and CRASH-3 trials
Our exploratory machine learning–based analysis of data from the CRASH-2 and CRASH-3 trials suggests that tranexamic acid should be administered as soon as
010
Reposted by Jan Hartmann, M.D.
International Society on Thrombosis and Haemostasis @isth.org · 29/04/2025
🎧️New ISTH Pulse Podcast episode alert! We’re excited to welcome Dr. Jerrold Levy! Tune in as he shares his journey through medicine, his passion for advancing global standards through the ISTH SSC & why getting involved in the scientific community is more important than ever 🔗Listen: bit.ly/3Gxg2iO
062
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 29/04/2025
This podcast episode with my favorite hematologist is a great resource for Sickle Cell Disease patients and their families and friends. #SCD #hemesky podcasts.apple.com/us/podcast/b...
podcasts.apple.com
How can families navigate sickle cell disease?
Podcast Episode · Boston Children's Answers Parentcast · 04/29/2025 · 22m
010
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 29/04/2025
www.sciencedirect.com/science/arti...
sciencedirect.com
Emergent cardiac surgery, andexanet alfa–induced heparin resistance, and prothrombotic effects: coagulation chaos?
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 27/04/2025
Please discuss. I will observe… 🍿 🍿 🍿 “Overall, there was little to no evidence of a difference between blood transfusion strategies for mortality or thromboembolic events.” www.cochrane.org/CD012635/CEN...
cochrane.org
Do different ways of giving blood or blood products to treat bleeding affect the risk of death or the risk of developing a blood clot in people who are bleeding heavily after a traumatic injury?
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 25/04/2025
eurointervention.pcronline.com/article/prog...
eurointervention.pcronline.com
Prognostic value of invasive versus echocardiography-derived aortic gradient in patients undergoing TAVI
Study on the prognostic value of invasive and echocardiography-derived gradients after TAVI with balloon-expandable and self-expanding valves.
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 25/04/2025
Looking forward to this event in June. Pres release here: www.newswire.com/news/german-...
000
Reposted by Jan Hartmann, M.D.
NEJM.org @nejm.org · 23/04/2025
In the SINGLE SHOT CHAMPION trial, pulsed field ablation was noninferior to cryoballoon ablation with respect to the incidence of a first recurrence of atrial tachyarrhythmia, as assessed by continuous rhythm monitoring. Full trial results and Research Summary: nej.md/4iH5zQe #MedSky #Afib
The New England Journal of Medicine     

Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation 

A Research Summary based on Reichlin T et al. | 10.1056/NEJMoa2502280 | Published on March 31, 2025 

Visual representations of the patients in the trial and the treatments they were assigned.         

Read the full Research Summary at NEJM.org.
073
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 22/04/2025
Requiescat in pace.
Pope Francis in the Vatican, Easter 2014.
000
Reposted by Jan Hartmann, M.D.
NEJM.org @nejm.org · 19/04/2025
In the SINGLE SHOT CHAMPION trial, pulsed field ablation was noninferior to cryoballoon ablation with respect to the incidence of a first recurrence of atrial tachyarrhythmia, as assessed by continuous rhythm monitoring. Learn more in a new Quick Take video: nej.md/42LlZ4f #MedSky
Illustration of continuous rhythm monitoring used to detect atrial tachyarrhythmias in a patient (left) and pulsed field ablation and cryoballoon ablation (right).
061
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 19/04/2025
journals.lww.com/jtrauma/full...
journals.lww.com
Where does cryoprecipitate fit into balanced resuscitation? ... : Journal of Trauma and Acute Care Surgery
o 8 U of red blood cells (RBCs). We describe transfusion ratios when cryoprecipitate was indicated by viscoelastic testing (VET) and evaluated whole blood (WB)'s impact on this ratio. METHODS Adult...
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 16/04/2025
jamanetwork.com/journals/jam...
jamanetwork.com
Hemorrhage Causes Most Maternal Deaths Worldwide
Obstetric hemorrhage remains the leading cause of maternal mortality, accounting for about 27% of deaths during pregnancy and the following 6 weeks, a new study has found.
000
Jan Hartmann, M.D. @janhartmannmd.bsky.social · 16/04/2025
Excellent review. www.nature.com/articles/s41...
nature.com
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism - Nature Reviews Cardiology
Inhibition of factor XI has emerged as a promising strategy to mitigate bleeding while potentially preserving antithrombotic efficacy. In this Review, the authors comprehensively discuss the rationale...
032